Australia markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
80.54-0.10 (-0.12%)
At close: 04:00PM EDT
80.54 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate0.991.174.645.54
Low estimate0.941.074.55.29
High estimate1.031.264.725.84
Year ago EPS1.421.026.094.64
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts5554
Avg. Estimate31.9M35.85M137.79M160.6M
Low estimate30.5M33.31M134M153.8M
High estimate33.56M38M141.3M170M
Year ago salesN/AN/A131.31M137.79M
Sales growth (year/est)N/AN/A4.90%16.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS0.640.610.660.78
Actual EPS1.421.021.381.2
Difference0.780.410.720.42
Surprise %121.90%67.20%109.10%53.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.991.174.645.54
7 days ago0.991.174.645.54
30 days ago0.991.174.645.54
60 days ago1.021.194.455.6
90 days ago1.021.194.455.6
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLGNDIndustrySector(s)S&P 500
Current qtr.-30.30%N/AN/AN/A
Next qtr.14.70%N/AN/AN/A
Current year-23.80%N/AN/AN/A
Next year19.40%N/AN/AN/A
Next 5 years (per annum)20.00%N/AN/AN/A
Past 5 years (per annum)12.40%N/AN/AN/A